A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint BlockadeLivnat Jerby‐Arnon, Charles H. Yoon, David Liu et al.|Cell|2018Cited by 1.5k
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinomaKevin Bi, Eliezer M. Van Allen, Meng Xiao He et al.|Cancer Cell|2021Cited by 624
A single-cell landscape of high-grade serous ovarian cancerBenjamin Izar, Aviv Regev, Itay Tirosh et al.|Nature Medicine|2020Cited by 522
Abstract PR01: A cancer cell program promotes T-cell exclusion and resistance to checkpoint blockadeParin Shah, Livnat Jerby‐Arnon, Michael S. Cuoco et al.|Cancer Research|2020Cited by 1
Abstract SY45-04: Development of therapeutic strategies by resolving the tumor ecosystemBenjamin Izar, Aviv Regev, Livnat Jerby‐Arnon et al.|Clinical Research (Excluding Clinical Trials)|2019Cited by 0